Uğur Şahin
M.D.
CEO and Co-founder, BioNTech
👥Biography 个人简介
Uğur Şahin is a pioneer in mRNA therapeutics and personalized cancer vaccines. He co-founded BioNTech, which has advanced mRNA technology for both infectious disease vaccines and cancer immunotherapy. Şahin's work on individualized neoantigen mRNA vaccines has shown promising clinical results, demonstrating the potential of personalized cancer vaccination based on patient-specific tumor mutations.
Uğur Şahin是mRNA治疗和个性化癌症疫苗的先驱。他共同创立了BioNTech,该公司推进了用于传染病疫苗和癌症免疫治疗的mRNA技术。Şahin在个体化新抗原mRNA疫苗方面的工作显示了令人鼓舞的临床结果,展示了基于患者特异性肿瘤突变的个性化癌症疫苗接种的潜力。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
mRNA Cancer Vaccines
Developed mRNA platform for personalized neoantigen cancer vaccines.
BioNTech Platform
Built integrated mRNA technology platform enabling rapid vaccine development.
Representative Works 代表性著作
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Nature (2017)
First demonstration of personalized mRNA neoantigen vaccine efficacy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-03-04 | All information from publicly available academic sources
Related Experts 相关专家
关注 Uğur Şahin 的研究动态
Follow Uğur Şahin's research updates
留下邮箱,当我们发布与 Uğur Şahin(BioNTech / University of Mainz)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment